Product News
Novel Diagnostic Test Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer
New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission
News & Articles
25
Selected Filters:
Product News
MammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC
First comparison of a biomarker analysis by RT-qPCR (MammaTyper®) versus visual or computer-assisted immunohistochemistry (IHC) in subtyping mammary carcinomas
Product News
Precise Quantitative Biomarker Detection for Molecular Breast Cancer Subtyping
Study confirms advantages of the in vitro diagnostic test kit MammaTyper® over immunohistochemistry